|
SEPT10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.916200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.512400E-01 |
| Normal-vs-Stage2 |
6.480800E-01 |
| Normal-vs-Stage3 |
1.983380E-03 |
| Normal-vs-Stage4 |
2.32519999999736E-05 |
| Stage1-vs-Stage2 |
8.256600E-01 |
| Stage1-vs-Stage3 |
1.778290E-03 |
| Stage1-vs-Stage4 |
4.99220000005351E-06 |
| Stage2-vs-Stage3 |
1.212560E-01 |
| Stage2-vs-Stage4 |
2.272000E-02 |
| Stage3-vs-Stage4 |
2.610400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.761900E-02 |
| Normal-vs-AfricanAmerican |
6.214600E-04 |
| Normal-vs-Asian |
9.461600E-01 |
| Caucasian-vs-AfricanAmerican |
1.759910E-02 |
| Caucasian-vs-Asian |
6.494600E-01 |
| AfricanAmerican-vs-Asian |
1.323970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.981300E-03 |
| Normal-vs-Female |
4.602800E-01 |
| Male-vs-Female |
3.543500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.636300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.362400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.638500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.520600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.315900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.338400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.924000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.953980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.765800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.564400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.818010E-01 |
| Normal-vs-Grade 2 |
5.659000E-01 |
| Normal-vs-Grade 3 |
3.475500E-03 |
| Normal-vs-Grade 4 |
8.10710054643948E-10 |
| Grade 1-vs-Grade 2 |
4.537200E-01 |
| Grade 1-vs-Grade 3 |
8.380100E-03 |
| Grade 1-vs-Grade 4 |
1.51912999999393E-05 |
| Grade 2-vs-Grade 3 |
4.11940000000222E-05 |
| Grade 2-vs-Grade 4 |
4.08928446660184E-12 |
| Grade 3-vs-Grade 4 |
5.93970000000166E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.160400E-03 |
| Normal-vs-ccB subtype |
3.80869999982991E-08 |
| ccA subtype-vs-ccB subtype |
1.62470037423645E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.375900E-02 |
| Normal-vs-N1 |
2.395800E-04 |
| N0-vs-N1 |
3.215800E-02 |
|
|
